Published by
@ShahidNShah
@ShahidNShah
The impact of COVID-19 on virtual trials
The need to accelerate virtual trials is just one takeout that Henry Levy, GM at Veeva Vault CDMS, talks about in an exclusive interview with MobiHealthNews, in which the impact of COVID-19 on the pharmaceutical industry is addressed.
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- Innovation in substance use disorder treatment: 5 Keys to Impact
- Fighting coronavirus using data collection: Latest for hospitals
- Why oncology experts are pushing for more diversity in cancer clinical trials
- A look inside Geisinger's new remote monitoring program for COVID-19 patients
- Telehealth App Breach Spotlights Privacy, Security Risks
Next Article
-
Innovation in substance use disorder treatment: 5 Keys to Impact
Flare Capital Partners reviews the current landscape of substance use disorder treatment and highlights some early-stage tech companies tackling the ongoing opioid epidemic.
Posted Jun 15, 2020addictioninnovation
